Japanese scientists are scanning the possibility of using an anti-malarial drug called mefloquine....
eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...
Vectura Group has signed an agreement with Australia-based Incannex Healthcare to provide pre-clinical development servi...
Rancho Santa Fe Bio, Inc. (RSF Bio), a San Diego, California-based clinical-stage cardiovascular platform company, annou...
Merck has signed a collaboration agreement with Janssen Pharmaceuticals NV around the commercialization of INVOKANA...
Peptron, Inc., a South Korea-based biotech company, and Qilu Pharmaceutical, a China-based pharmaceutical company f...
The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company developing treatments ...
SK Biopharmaceuticals, Co., Ltd., a global innovative pharmaceutical company, announced that cenobamate received marketi...
Sydney-based Kazia Therapeutics Limited, an oncology-focused drug development company announced that it has entered into...
Astellas Pharma Inc. announced on March 31, 2021, that XOSPATA® (generic name: gilteritinib) is now available for pr...
Eisai Co., Ltd. announced on March 30, 2021 that the European Medicines Agency (EMA) has confirmed it has acce...
EirGenix, Inc. announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimi...
Japanese firm Eisai Co., Ltd. as part of its strategic investment to realize its medium-term management plan, EWAY ...
Eisai Co., Ltd. announced that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has obtained approval for the in-hou...
Eisai Co., Ltd. has announced that Eisai Korea Inc., (Eisai's subsidiary in South Korea) has launched the Parkinson's di...
Standigm Inc, an artificial intelligence (AI)-based drug discovery company and SK Chemicals Co, Ltd, a life science and ...
Chugai Pharmaceutical Co., Ltd. announced that Chugai Pharma Taiwan Ltd., a wholly-owned subsidiary of Chugai, obta...
AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chro...
Gilead Sciences K.K. (Head office: Chiyoda-ku, Tokyo; President and Representative Director: Luc Hermans) and Eisai Co.,...
Singapore's Health Sciences Authority (HSA) recently approved an immunotherapy regimen (Tecentriq + Avastin) t...
A NEW therapy to treat advanced gastrointestinal stromal tumours (GIST) will be available to patients in Australia,...
TaiGen Biotechnology Company, Limited (TaiGen) in Taiwan has announced that U.S. Food and Drug Administration (FDA) has ...
Microcrystal electron diffraction (MicroED) is a new crystal structure determination technique for small molecules. It o...
Japanese firm FUJIFILM Toyama Chemical Co., Ltd. has announced that the company filed an Application for Partial Changes...
The Indian state, Maharashtra has become the first to fix the price of remdesivir at INR2,360 (US$32.17), which is 16% m...
